Artal Group S.A. - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$44
-87.7%
2,042,6660.0%0.00%
-85.0%
Q4 2022$357
-100.0%
2,042,6660.0%0.02%
-47.4%
Q3 2022$886,000
-71.9%
2,042,666
-44.8%
0.04%
-77.4%
Q2 2022$3,149,000
-84.6%
3,701,5800.0%0.17%
-80.3%
Q1 2022$20,396,000
-43.1%
3,701,5800.0%0.85%
-12.1%
Q4 2021$35,831,000
-51.8%
3,701,580
-10.9%
0.97%
-41.5%
Q3 2021$74,303,000
-34.3%
4,155,625
-10.3%
1.66%
-27.6%
Q2 2021$113,111,000
-12.6%
4,633,791
-5.1%
2.30%
+0.4%
Q1 2021$129,420,000
+351.2%
4,883,791
+29.2%
2.29%
+271.3%
Q4 2020$28,682,000
+51.5%
3,778,9130.0%0.62%
+33.9%
Q3 2020$18,932,000
-17.8%
3,778,913
-1.9%
0.46%
-28.7%
Q2 2020$23,037,000
+33.3%
3,852,341
-0.8%
0.64%
-11.6%
Q1 2020$17,283,000
-35.8%
3,883,791
+37.1%
0.73%
-29.8%
Q4 2019$26,921,000
+21.0%
2,833,7910.0%1.04%
+16.6%
Q3 2019$22,246,000
-50.1%
2,833,7910.0%0.89%
-50.5%
Q2 2019$44,576,000
-15.3%
2,833,791
-2.6%
1.80%
-16.1%
Q1 2019$52,650,000
+12.6%
2,908,7910.0%2.15%
+24.1%
Q4 2018$46,773,000
-33.0%
2,908,7910.0%1.73%
-4.6%
Q3 2018$69,811,0002,908,7911.82%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders